Effects of pristimerin on proliferation, migration and cell cycle of colorectal cancer HCT116 and HT29 cells and its action mechanism

LYU Mengying; LUO Zhaoyong; WANG Weimin; LIANG Qiaoling; WANG Yang; QIAN Yayun; LIU Yanqing

doi:10.7619/jcmp.20220335

Journal of Clinical Medicine in Practice > 2022 > 26(13): 60-67. > DOI: 10.7619/jcmp.20220335

LYU Mengying, LUO Zhaoyong, WANG Weimin, LIANG Qiaoling, WANG Yang, QIAN Yayun, LIU Yanqing. Effects of pristimerin on proliferation, migration and cell cycle of colorectal cancer HCT116 and HT29 cells and its action mechanism[J]. Journal of Clinical Medicine in Practice, 2022, 26(13): 60-67. DOI: 10.7619/jcmp.20220335

Citation:

PDF (4671 KB)

Effects of pristimerin on proliferation, migration and cell cycle of colorectal cancer HCT116 and HT29 cells and its action mechanism

LYU Mengying^{1, 2},
LUO Zhaoyong^{1, 2},
WANG Weimin^{1, 2},
LIANG Qiaoling^{1, 2},
WANG Yang^{1, 2},
QIAN Yayun^{1, 2},
LIU Yanqing^{1, 2, ,}

1.
Medical College of Yangzhou University, Institute of Translational Medicine, Yangzhou, Jiangsu, 225001
2.
The Key Laboratory of Syndrome Differentiation and Treatment of Toxic Pathogen-based Gastric Cancer of the State Administration of Traditional Chinese Medicine, Yangzhou, Jiangsu, 225001

More Information

Received Date: January 25, 2022
Available Online: July 01, 2022

Graphical Abstract

Abstract

Abstract

Objective
To investigate impacts of pristimerin on proliferation, migration and cell cycle of colorectal cancer HCT116 and HT29 cells and uncover the potential mechanism.
Methods
Cell viability of HCT116 and HT29 cells treated with pristimerin at various concentrations was measured by Methyl Thiazolyl Tetrazolium (MTT) assay at different time points. The proliferation of HCT116 cells and HT29 cells treated with pristimerin at various concentrations was detected by 5-acetyney-2'-deoxyuridine (EdU) assay. Transwell experiment was performed to observe the effects of different concentrations of pristimerin on migration of HCT116 cells and HT29 cells. The influence of pristimerin on cell cycle of HCT116 cells and HT29 cells was tested by flow cytometry. Western blot was used to determine its impact on cell cycle-related proteins including cyclin E1, CDK2, p53, p27 and p21 as well as PI3K/Akt/mTOR signaling pathways.
Results
MTT tests revealed that the viability of HCT116 and HT29 cells after 12, 24, 36, 48 and 60 h treated by different concentrations of pristimerin decreased significantly, and changed in a dose and time-dependent manner. EdU tests showed that the positive cell rates of HCT116 cells treated with 0.5, 1, 2 μmol/L pristimerin for 24 h were lower than those of the control group, the difference was statistically significant (P < 0.001). After treatment with 1, 2 and 4 μmol/L pristimerin for 24 h, the positive cell rates of HT29 cells were lower than those of the control group, the difference was statistically significant (P < 0.001). Transwell experiment results showed that the number of HCT116 cells penetrating the subventricular membrane decreased, and the cell migration rates were lower than that of control cells after treatment with 0.5, 1, 2 μmol/L pristimerin for 24 h (P < 0.001). Flow cytometry results showed that pristimerin could induce cell cycle arrest of HCT116 and HT29 cells at G₀/G₁ stages. Western blot results displayed that p53, p21 and p27 protein expression were up-regulated and the expression of cyclin E1, CDK2, p-PI3K, p-Akt, mTOR and p-mTOR was down-regulated in HCT116 and HT29 cells treated by pristimerin(P < 0.05, P < 0.01 or P < 0.001).
Conclusion
Pristimerin could exert the proliferation and migration of HCT116 and HT29 cells, induce arrest at G₀/G₁ stages, and the molecular mechanism may be related to PI3K/Akt/mTOR signaling pathway.
- pristimerin,
- colorectal cancer,
- proliferation,
- migration,
- cell cycle,
- signaling pathway

FullText(HTML)

References (27)

References

[1]	KISHORE C, BHADRA P. Current advancements and future perspectives of immunotherapy in colorectal cancer research[J]. Eur J Pharmacol, 2021, 893: 173819. doi: 10.1016/j.ejphar.2020.173819
[2]	PIAWAH S, VENOOK A P. Targeted therapy for colorectal cancer metastases: a review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer[J]. Cancer, 2019, 125(23): 4139-4147. doi: 10.1002/cncr.32163
[3]	林先勇, 张西志. 血管生成抑制剂恩度联合化疗治疗晚期结直肠癌的研究进展[J]. 实用临床医药杂志, 2018, 22(11): 128-132. doi: 10.7619/jcmp.201811038
[4]	JIANG Z Z, ZHAO Y, ZHAO Y, et al. Pristimerin synergizes with gemcitabine through abrogating Chk1/53BP1-mediated DNA repair in pancreatic cancer cells[J]. Food Chem Toxicol, 2021, 147: 111919. doi: 10.1016/j.fct.2020.111919
[5]	LI J J, YAN Y Y, SUN H M, et al. Anti-cancer effects of pristimerin and the mechanisms: a critical review[J]. Front Pharmacol, 2019, 10: 746. doi: 10.3389/fphar.2019.00746
[6]	ZHAO Q, CHENG X R, YU W, et al. Pristimerin induces apoptosis and tumor inhibition of oral squamous cell carcinoma through activating ROS-dependent ER stress/Noxa pathway[J]. Phytomedicine, 2021, 92: 153723. doi: 10.1016/j.phymed.2021.153723
[7]	ZHAO Q, BI Y, ZHONG J, et al. Pristimerin suppresses colorectal cancer through inhibiting inflammatory responses and Wnt/β-catenin signaling[J]. Toxicol Appl Pharmacol, 2020, 386: 114813. doi: 10.1016/j.taap.2019.114813
[8]	ZHAO Q, LIU Y X, ZHONG J, et al. Pristimerin induces apoptosis and autophagy via activation of ROS/ASK₁/JNK pathway in human breast cancer in vitro and in vivo[J]. Cell Death Discov, 2019, 5: 125. doi: 10.1038/s41420-019-0208-0
[9]	LI J J, GUO Q R, LEI X P, et al. Pristimerin induces apoptosis and inhibits proliferation, migration in H1299 lung cancer cells[J]. J Cancer, 2020, 11(21): 6348-6355. doi: 10.7150/jca.44431
[10]	LEE S O, KIM J S, LEE M S, et al. Anti-cancer effect of pristimerin by inhibition of HIF-1α involves the SPHK-1 pathway in hypoxic prostate cancer cells[J]. BMC Cancer, 2016, 16: 701. doi: 10.1186/s12885-016-2730-2
[11]	WANG W M, LI D, XIANG L L, et al. TIMP-2 inhibits metastasis and predicts prognosis of colorectal cancer via regulating MMP-9[J]. Cell Adh Migr, 2019, 13(1): 273-284.
[12]	CANTERO-CID R, MONTALBÁN-HERNÁNDEZ K M, GUEVARA J, et al. Intertwined leukocyte balances in tumours and peripheral blood as robust predictors of right and left colorectal cancer survival[J]. World J Gastrointest Oncol, 2022, 14(1): 295-318. doi: 10.4251/wjgo.v14.i1.295
[13]	陈志强, 蔡光先. 中西医结合内科学[M]. 2版. 北京: 中国中医药出版社, 2012: 123-130.
[14]	吴继萍, 冯妮, 李晓林, 等. 中医辨证论治结直肠癌术后的临床研究[J]. 光明中医, 2011, 26(9): 1816-1818. doi: 10.3969/j.issn.1003-8914.2011.09.039
[15]	钟俐强, 杨斯皓, 周珍, 等. 从中医方剂学角度谈癌性疼痛治疗的君臣佐使[J]. 四川中医, 2016, 34(3): 44-45. https://www.cnki.com.cn/Article/CJFDTOTAL-SCZY201603021.htm
[16]	LIM S, KALDIS P. Cdks, cyclins and CKIs: roles beyond cell cycle regulation[J]. Dev Camb Engl, 2013, 140(15): 3079-3093.
[17]	XIE J, LUO F X, SHI C Y, et al. Moringa oleifera alkaloids inhibited PC3 cells growth and migration through the COX-2 mediated Wnt/β-catenin signaling pathway[J]. Front Pharmacol, 2020, 11: 523962.
[18]	XU Y, NASRI M, DANNENMANN B, et al. NAMPT/SIRT2-mediated inhibition of the p53-p21 signaling pathway is indispensable for maintenance and hematopoietic differentiation of human iPS cells[J]. Stem Cell Res Ther, 2021, 12(1): 112. doi: 10.1186/s13287-021-02144-9
[19]	STUBBS C K, BIANCUCCI M, VIDIMAR V, et al. RAS specific protease induces irreversible growth arrest via p27 in several KRAS mutant colorectal cancer cell lines[J]. Sci Rep, 2021, 11(1): 17925. doi: 10.1038/s41598-021-97422-0
[20]	COLEMAN N, MOYERS J T, HARBERY A, et al. Clinical development of AKT inhibitors and associated predictive biomarkers to guide patient treatment in cancer medicine[J]. Pharmacogenomics Pers Med, 2021, 14: 1517-1535.
[21]	NOOROLYAI S, SHAJARI N, BAGHBANI E, et al. The relation between PI3K/AKT signalling pathway and cancer[J]. Gene, 2019, 698: 120-128. doi: 10.1016/j.gene.2019.02.076
[22]	ALZAHRANI A S. PI3K/Akt/mTOR inhibitors in cancer: at the bench and bedside[J]. Semin Cancer Biol, 2019, 59: 125-132. doi: 10.1016/j.semcancer.2019.07.009
[23]	POLIVKA J, JANKU F. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway[J]. Pharmacol Ther, 2014, 142(2): 164-175. doi: 10.1016/j.pharmthera.2013.12.004
[24]	DIN S, NISAR M, RAMZAN M, et al. Latcripin-7A from Lentinula edodes C induces apoptosis, autophagy, and cell cycle arrest at G1 phase in human gastric cancer cells via inhibiting PI3K/Akt/mTOR signaling[J]. Eur J Pharmacol, 2021, 907: 174305. doi: 10.1016/j.ejphar.2021.174305
[25]	CAO W, LIU X, ZHANG Y, et al. BEZ235 increases the sensitivity of hepatocellular carcinoma to sorafenib by inhibiting PI3K/AKT/mTOR and inducing autophagy[J]. Biomed Res Int, 2021, 2021: 5556306.
[26]	MORI Y, SHIRAI T, TERAUCHI R, et al. Antitumor effects of pristimerin on human osteosarcoma cells in vitro and in vivo[J]. Oncotargets Ther, 2017, 10: 5703-5710. doi: 10.2147/OTT.S150071
[27]	YAN F X, LIAO R F, SILVA M, et al. Pristimerin-induced uveal melanoma cell death via inhibiting PI3K/Akt/FoxO3a signalling pathway[J]. J Cell Mol Med, 2020, 24(11): 6208-6219. doi: 10.1111/jcmm.15249

[1]	XU Hexi, SONG Hongqi, LIU Dianwen, LIU Shiju, YANG Huiju. Effect of silencing E26 transformation-specific sequence 4 on proliferation and migration of colon cancer cells by inhibiting nuclear factor-κB signaling pathway[J]. Journal of Clinical Medicine in Practice, 2025, 29(2): 38-41,47. DOI: 10.7619/jcmp.20243267
[2]	ZHU Jiameng, SUN Longhe, SUN Qiannan, REN Jun, LIU Bin, WANG Liuhua, WANG Daorong. Regulatory role and mechanism of mitochondrial ribosomal protein S35 in proliferation, invasion, and migration of colon cancer cells[J]. Journal of Clinical Medicine in Practice, 2025, 29(2): 24-31,37. DOI: 10.7619/jcmp.20244162
[3]	ZHONG Xinqiang, CHEN Kang, DU Heng, XIAO Haipeng, LU Yanjun, WU Anding. Experimental study in vitro of ziyuglycoside Ⅱ in inhibition of proliferation, migration, invasion and induction of apoptosis of colon cancer cells[J]. Journal of Clinical Medicine in Practice, 2024, 28(1): 7-12. DOI: 10.7619/jcmp.20232690
[4]	WANG Zhenglin, CHANG Weicai, LIU Xinyu, CHEN Jiawei, LIU Zixiang, ZHOU Shaobo. Role of tumor necrosis factor-α in promoting gallbladder cancer cell proliferation through Wnt/β-catenin signaling pathway[J]. Journal of Clinical Medicine in Practice, 2023, 27(19): 40-45. DOI: 10.7619/jcmp.20230255
[5]	QIN Lei, QIN Xin. Myeloid differentiation factor 88 regulates the proliferation, migration and invasion of colorectal cancer cells through the nuclear factor-κB/activator protein-1 signaling pathway[J]. Journal of Clinical Medicine in Practice, 2023, 27(14): 40-45. DOI: 10.7619/jcmp.20223737
[6]	ZHANG Feng, ZHENG Gang, QI Jing, GAO Yuan. Research progress of inflammatory signaling pathway associated with atherosclerosis[J]. Journal of Clinical Medicine in Practice, 2022, 26(10): 144-148. DOI: 10.7619/jcmp.20214777
[7]	SHAO Yang, YAO Chao, XU Songyuan, QIANG Ping. MicroRNA-106 affects the biological behavior of endometrial cancer RL95-2 cells by regulating the PTEN/PI3K/AKT signaling pathway[J]. Journal of Clinical Medicine in Practice, 2022, 26(8): 104-110. DOI: 10.7619/jcmp.20214674
[8]	XIA Deguo, YAN Keshi, LU Dahao, ZHANG Chi, GAO Ju. Study on remifentanilin inhibiting Notch signal pathway and cell growth of human hepatocarcinoma cells[J]. Journal of Clinical Medicine in Practice, 2022, 26(8): 32-36. DOI: 10.7619/jcmp.20214486
[9]	WEN Bo, LIU Zixiang, ZHANG Ziyan, CHEN Jiawei, WANG Zhenglin, ZHOU Shaobo. Effect of overexpression of heparanase on proliferation of gallbladder cancer cells and PI3K/AKT signaling pathway[J]. Journal of Clinical Medicine in Practice, 2022, 26(2): 56-61. DOI: 10.7619/jcmp.20213823
[10]	CAO Qin, WANG Dan. Mechanism of ropivacaine inhibiting the proliferation, migration and invasion of gastric cancer cell NCI-N87 through Wnt signaling pathway[J]. Journal of Clinical Medicine in Practice, 2021, 25(20): 56-60, 67. DOI: 10.7619/jcmp.20211771

Cited By

Cited by

Periodical cited type(34)

1.	魏旭霞，宋丹丹，赵旭. 基于思维导图构建通气治疗重症肺炎新生儿的协作式“零缺陷”护理模式. 河南医学研究. 2025(03): 563-565 .
2.	张煜晶，王娟，李丽颖，卓瑞燕. 抚触联合三阶梯俯卧位干预在早产儿持续气道内正压通气治疗中的应用. 福建医药杂志. 2024(01): 176-178 .
3.	齐娟. 袋鼠式护理配合婴儿抚触对新生儿睡眠的影响. 中国城乡企业卫生. 2024(04): 72-74 .
4.	曾慧芳. 趣味视频示范联合抚触护理干预对肺炎患儿呼吸循环状况及康复进程的影响. 医学信息. 2024(18): 189-192 .
5.	陈小玲，姚小琴，颜惠萍，吴明锦，施月菊. 改良俯卧位通气联合按摩抚触在低出生体重儿机械通气中的应用. 中外医学研究. 2024(30): 65-68 .
6.	林梅莲，商孟芳. 非语言性沟通联合预警护理模式对肺炎支原体肺炎婴幼儿哭闹频率及睡眠质量的影响. 世界睡眠医学杂志. 2024(11): 2504-2506+2510 .
7.	许丹萍，叶严丽. 基于发展性照护的多维护理对新生儿肺炎患儿应激反应、生长发育的影响. 中国医药科学. 2023(10): 129-132 .
8.	张婷. 抚触护理在新生儿肺炎中的应用. 妇儿健康导刊. 2023(24): 148-150 .
9.	郑红娟. 音乐疗法结合安抚、抚触护理对眼科疾病患儿抗拒情绪及配合度的影响. 临床医学研究与实践. 2022(02): 154-156 .
10.	兰海利，姜艳丽，连金利. 体位护理对肺炎新生儿痰液排出及住院时间的影响. 黑龙江医药科学. 2022(01): 136-138+141 .
11.	左广霞，高香花，李晓燕. 以治疗性抚触为主的康复干预应用于重症肺炎BAL治疗中的效果观察. 中国疗养医学. 2022(06): 617-619 .
12.	阎洁，程功梅. 早期口腔运动训练联合新生儿抚触在晚期早产儿护理中的应用效果. 中国医药导报. 2022(13): 181-184 .
13.	陈燕琼. 早期抚触支持护理对新生儿母乳喂养及生理性黄疸的影响研究. 中外医疗. 2022(07): 127-131 .
14.	刘佩. 体位变换联合抚触护理对肺炎新生儿奶摄取量及呼吸循环功能的影响. 基层医学论坛. 2022(26): 88-90 .
15.	张红利，张慧，王金永. 协同干预模式对产科新生儿听力筛查初筛结果的影响. 中国实用医刊. 2022(16): 60-63 .
16.	付延霞，王丽，孟芳铭，胡莹莹，王晓辉. 康复护理在新生儿肺炎纤维支气管镜肺泡灌洗治疗中的应用效果. 护理实践与研究. 2021(01): 111-113 .
17.	吴颖，鲁金金. 抚触联合童趣化健康教育对癫痫患儿治疗依从性及生活质量影响. 社区医学杂志. 2021(05): 305-309 .
18.	朱红丹. 抚触护理干预对新生儿肺炎心理运动功能、智能发育的影响. 航空航天医学杂志. 2021(06): 759-760 .
19.	李敏. 早产儿发展性照顾护理的进展及前景. 基层医学论坛. 2021(24): 3534-3536 .
20.	赵小佳，唐金草，刘玲玲. 循证药学联合抚触护理在小儿反复呼吸道感染中的应用效果. 河南医学研究. 2021(24): 4583-4585 .
21.	徐传艳. 细节及舒适护理联合支气管肺炎排痰仪在小儿肺炎中的应用效果. 当代护士(下旬刊). 2021(10): 86-88 .
22.	林少芳. 抚触护理配合耳道护理对新生儿听力筛查测试结果的影响. 中国卫生标准管理. 2021(20): 126-129 .
23.	刘瑞荣. 俯卧位通气干预联合按摩抚触在新生儿肺炎护理中的应用价值分析. 现代诊断与治疗. 2021(22): 3663-3664 .
24.	李茸茸，张璐. 抚触联合游泳在新生儿胆红素脑病护理中的应用. 护理研究. 2020(08): 1351-1355 .
25.	刘萍，房艳荣. 家庭参与式护理在新生儿护理管理中的应用效果及对新生儿生长发育的影响. 临床医学研究与实践. 2020(13): 176-178 .
26.	齐丽. 抚触护理对新生儿肺炎患儿心理运动功能及智能发育的影响. 中国民康医学. 2020(07): 146-147 .
27.	杨静. 抚触护理措施应用于新生儿肺炎的护理价值研究. 实用临床护理学电子杂志. 2020(16): 130+132 .
28.	房艳荣，刘萍. 抚触护理对新生儿黄疸及其预后的影响. 临床医学研究与实践. 2020(16): 177-179 .
29.	周田，董芳香. 新生儿抚触护理对早期新生儿生长发育的应用价值体会. 人人健康. 2020(12): 226 .
30.	杨月萍. 婴儿生长发育在抚触护理下的效果观察. 实用临床护理学电子杂志. 2020(25): 161-162 .
31.	叶欢. 人性化护理模式在新生儿肺炎护理中的综合效果观察. 中国继续医学教育. 2020(19): 192-193 .
32.	于丹丹. 抚触不同开始时间对新生儿体格发育、智能发育及神经发育的影响. 中国医药指南. 2020(20): 168-169 .
33.	陈新. 研究抚触联合康复护理对新生儿缺氧缺血性脑病患儿生长发育的影响. 中国实用医药. 2020(21): 176-178 .
34.	李莲. 心理护理方法在新型冠状病毒肺炎患者中的应用价值. 青海医药杂志. 2020(06): 62-63 .

Other cited types(0)

Get Citation

PDF

XML

Article views (215) PDF downloads (25) Cited by(34)

Turn off MathJax

Article Contents

Abstract

References

Effects of pristimerin on proliferation, migration and cell cycle of colorectal cancer HCT116 and HT29 cells and its action mechanism